Heliyon,
Journal Year:
2024,
Volume and Issue:
10(16), P. e35083 - e35083
Published: July 23, 2024
The
use
of
MRI
analysis
for
BTD
and
tumor
type
detection
has
considerable
importance
within
the
domain
machine
vision.
Numerous
methodologies
have
been
proposed
to
address
this
issue,
significant
progress
achieved
in
via
deep
learning
(DL)
approaches.
While
majority
offered
approaches
using
artificial
neural
networks
(ANNs)
(DNNs)
demonstrate
satisfactory
performance
Bayesian
Tree
Descent
(BTD),
none
these
research
studies
can
ensure
optimality
employed
model
structure.
Put
simply,
there
is
room
improvement
efficiency
models
BTD.
This
introduces
a
novel
approach
optimizing
configuration
Convolutional
Neural
Networks
(CNNs)
Artificial
issue.
suggested
employs
(CNN)
purpose
segmenting
brain
MRIs.
model's
configurable
hyper-parameters
are
tuned
genetic
algorithm
(GA).
Multi-Linear
Principal
Component
Analysis
(MPCA)
used
decrease
dimensionality
segmented
features
pictures
after
they
segmented.
Ultimately,
segmentation
procedure
executed
an
Network
(ANN).
In
network
(ANN),
(GA)
sets
ideal
number
neurons
hidden
layer
appropriate
weight
vector.
effectiveness
was
assessed
by
utilizing
BRATS2014
BTD20
databases.
results
indicate
that
method
classify
samples
from
two
databases
with
average
accuracy
98.6
%
99.1
%,
respectively,
which
represents
at
least
1.1
over
preceding
methods.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 917 - 917
Published: Jan. 22, 2025
Advances
in
neuro-oncology
have
transformed
the
diagnosis
and
management
of
brain
tumors,
which
are
among
most
challenging
malignancies
due
to
their
high
mortality
rates
complex
neurological
effects.
Despite
advancements
surgery
chemoradiotherapy,
prognosis
for
glioblastoma
multiforme
(GBM)
metastases
remains
poor,
underscoring
need
innovative
diagnostic
strategies.
This
review
highlights
recent
imaging
techniques,
liquid
biopsies,
artificial
intelligence
(AI)
applications
addressing
current
challenges.
Advanced
including
diffusion
tensor
(DTI)
magnetic
resonance
spectroscopy
(MRS),
improve
differentiation
tumor
progression
from
treatment-related
changes.
Additionally,
novel
positron
emission
tomography
(PET)
radiotracers,
such
as
18F-fluoropivalate,
18F-fluoroethyltyrosine,
18F-fluluciclovine,
facilitate
metabolic
profiling
high-grade
gliomas.
Liquid
biopsy,
a
minimally
invasive
technique,
enables
real-time
monitoring
biomarkers
circulating
DNA
(ctDNA),
extracellular
vesicles
(EVs),
cells
(CTCs),
tumor-educated
platelets
(TEPs),
enhancing
precision.
AI-driven
algorithms,
convolutional
neural
networks,
integrate
tools
accuracy,
reduce
interobserver
variability,
accelerate
clinical
decision-making.
These
innovations
advance
personalized
neuro-oncological
care,
offering
new
opportunities
outcomes
patients
with
central
nervous
system
tumors.
We
advocate
future
research
integrating
these
into
workflows,
accessibility
challenges,
standardizing
methodologies
ensure
broad
applicability
neuro-oncology.
Sensors,
Journal Year:
2025,
Volume and Issue:
25(9), P. 2746 - 2746
Published: April 26, 2025
A
brain
tumor
is
the
result
of
abnormal
growth
cells
in
central
nervous
system
(CNS),
widely
considered
as
a
complex
and
diverse
clinical
entity
that
difficult
to
diagnose
cure.
In
this
study,
we
focus
on
current
advances
medical
imaging,
particularly
magnetic
resonance
imaging
(MRI),
how
machine
learning
(ML)
deep
(DL)
algorithms
might
be
combined
with
assessments
improve
diagnosis.
Due
its
superior
contrast
resolution
safety
compared
other
methods,
MRI
highlighted
preferred
modality
for
tumors.
The
challenges
related
analysis
different
processes
including
detection,
segmentation,
classification,
survival
prediction
are
addressed
along
ML/DL
approaches
significantly
these
steps.
We
systematically
analyzed
107
studies
(2018–2024)
employing
ML,
DL,
hybrid
models
across
publicly
available
datasets
such
BraTS,
TCIA,
Figshare.
light
recent
developments
analysis,
many
have
been
proposed
accurately
obtain
ontological
characteristics
tumors,
enhancing
diagnostic
precision
personalized
therapeutic
strategies.
Electronics,
Journal Year:
2024,
Volume and Issue:
13(2), P. 364 - 364
Published: Jan. 15, 2024
In
the
domain
of
radiological
diagnostics,
accurately
detecting
and
classifying
brain
tumors
from
magnetic
resonance
imaging
(MRI)
scans
presents
significant
challenges,
primarily
due
to
complex
diverse
manifestations
in
these
scans.
this
paper,
a
convolutional-block-based
architecture
has
been
proposed
for
detection
multiclass
using
MRI
Leveraging
strengths
CNNs,
our
framework
demonstrates
robustness
efficiency
distinguishing
between
different
tumor
types.
Extensive
evaluations
on
three
datasets
underscore
model’s
exceptional
diagnostic
accuracy,
with
an
average
accuracy
rate
97.52%,
precision
97.63%,
recall
97.18%,
specificity
98.32%,
F1-score
97.36%.
These
results
outperform
contemporary
methods,
including
state-of-the-art
(SOTA)
models
such
as
VGG16,
VGG19,
MobileNet,
EfficientNet,
ResNet50,
Xception,
DenseNet121.
Furthermore,
its
adaptability
across
modalities
underlines
potential
broad
clinical
application,
offering
advancement
field
diagnostics
detection.
IEEE Access,
Journal Year:
2024,
Volume and Issue:
12, P. 78843 - 78853
Published: Jan. 1, 2024
Brain
tumors
present
significant
health
risks
due
to
abnormal
cell
growth,
potentially
leading
organ
dysfunction
and
mortality
in
adults.
Magnetic
resonance
imaging
(MRI)
is
crucial
for
tumor
classification,
but
limited
expertise
this
area
necessitates
advanced
methods
accurate
diagnosis.
Deep
Learning
has
emerged
as
a
pivotal
tool,
yet
gaps
remain
achieving
optimal
accuracy.
This
study
addresses
these
by
proposing
an
enhanced
model
classifying
meningioma,
glioma,
pituitary
gland
tumors,
thereby
improving
precision
brain
detection.
Trained
on
dataset
of
5712
images,
the
achieves
exceptional
accuracy
(99%)
both
training
validation
datasets,
with
focus
precision.
Leveraging
techniques
such
data
augmentation,
transfer
learning
ResNet50,
regularization
ensures
stability
generalizability.
Evaluation
1311-image
test
set
reveals
outstanding
class-specific
accuracies
(glioma:
98.33%,
meningioma:
94.44%,
no
tumor:
100.00%,
pituitary:
100.00%).
Comprehensive
metrics
including
(0.983559),
recall
(0.983219),
F1
score
(0.983140),
AUC
(ROC)
(0.999038)
underscore
model's
efficacy.
demonstrates
potential
deep
early
diagnosis,
surpassing
conventional
laying
robust
foundation
future
research
neural
network-based
classification
algorithms
tumors.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(2), P. 274 - 274
Published: Jan. 8, 2024
Ultrasonography
is
the
preferred
modality
for
detailed
evaluation
of
enlarged
lymph
nodes
(LNs)
identified
on
computed
tomography
and/or
magnetic
resonance
imaging,
owing
to
its
high
spatial
resolution.
However,
diagnostic
performance
ultrasonography
depends
examiner's
expertise.
To
support
ultrasonographic
diagnosis,
we
developed
YOLOv7-based
deep
learning
models
metastatic
LN
detection
and
compared
their
with
that
highly
experienced
radiologists
less
residents.
We
enrolled
462
B-
D-mode
ultrasound
images
261
279
non-metastatic
histopathologically
confirmed
LNs
from
126
patients
head
neck
squamous
cell
carcinoma.
The
were
optimized
using
training
validation
was
evaluated
testing
images,
respectively.
model's
comparable
superior
residents'
reading
whereas
B-mode
higher
than
residents
but
lower
images.
Thus,
can
assist
in
diagnoses.
model
could
raise
same
level
as
radiologists.